MITOCHON PHARMACEUTICALS

mitochon-pharmaceuticals-logo

Mitochon Pharmaceuticals is a start-up biotech company, formed in 2014, that focuses on developing drugs that target the mitochondria for a host of serious diseases with significant unmet medical needs. Their development programs are primarily focused on neurodegenerative & neuromuscular diseases including: Huntington’s, Batten Disease, Stroke, Duchenne Muscular Dystrophy (DMD), Alzheimer’s Disease, Parkinson Disease and severe burns, and secondarily on metabolic disorders due to over-nutrit... ion (diabetes, obesity and NASH). On-going research has linked these diseases to various malfunctions of the mitochondria. By correcting them, Mitochon aims at opening the way for a broad range of disease modifying therapies. Mitochon is led by a team of industry executives with over 80-years of combined experience and a passion to bring forward breakthrough drug therapies for a host of devastating diseases.

#SimilarOrganizations #People #Financial #Website #More

MITOCHON PHARMACEUTICALS

Social Links:

Industry:
Biopharma Biotechnology Pharmaceutical

Founded:
2014-01-01

Address:
Radnor, Pennsylvania, United States

Country:
United States

Website Url:
http://www.mitochonpharma.com

Total Employee:
1+

Status:
Active

Total Funding:
2.33 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

boston-pharmaceuticals-logo

Boston Pharmaceuticals

Boston Pharmaceuticals Provides Healthcare Services.

corvus-pharmaceuticals-logo

Corvus Pharmaceuticals

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

inversago-pharma-logo

Inversago Pharma

Inversago Pharma is a specialized, preclinical-stage biotech company.

not_available_image

Triptcor Pharmaceuticals

Triptcor Pharmaceuticals, a start-up based on inflammatory disease.

Current Employees Featured

john-g-geisler_image

John G. Geisler
John G. Geisler Founder & Chief Scientific Officer @ Mitochon Pharmaceuticals
Founder & Chief Scientific Officer

not_available_image

Robert Alonso
Robert Alonso Founder & CEO @ Mitochon Pharmaceuticals
Founder & CEO

Founder


john-g-geisler_image

John G. Geisler

not_available_image

Robert Alonso

Investors List

ben-franklin-technology-partners-of-southeastern-pennsylvania_image

Ben Franklin Technology Partners of Southeastern Pennsylvania

Ben Franklin Technology Partners of Southeastern Pennsylvania investment in Venture Round - Mitochon Pharmaceuticals

ben-franklin-technology-partners-of-southeastern-pennsylvania_image

Ben Franklin Technology Partners of Southeastern Pennsylvania

Ben Franklin Technology Partners of Southeastern Pennsylvania investment in Seed Round - Mitochon Pharmaceuticals

Official Site Inspections

http://www.mitochonpharma.com Semrush global rank: 4.95 M Semrush visits lastest month: 1.73 K

  • Host name: 271398.cloudwaysapps.com
  • IP address: 69.55.49.48
  • Location: North Bergen United States
  • Latitude: 40.793
  • Longitude: -74.0247
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 07047

Loading ...

More informations about "Mitochon Pharmaceuticals" on Search Engine

Mitochon Pharmaceuticals - Crunchbase Company Profile

Mitochon Pharmaceuticals is a start-up biotech company, formed in 2014, that focuses on developing drugs that target the mitochondria for a host of serious diseases with …See details»

Mitochon Pharmaceuticals - MitochondriaWorld - mitoworld.org

Mitochon Pharmaceuticals. Mission Statement. Our mission is to bring forward meaningful drugs that work at the root of insidious diseases by direct modulation of the …See details»

Mitochon Pharmaceuticals, Inc. | LinkedIn

Mitochon Pharmaceuticals is a clinically staged biotech that is focused on developing drugs that target the mitochondria for a host of serious diseases with significant unmet …See details»

Mitochon Pharmaceuticals: Channeling the Ability of Mitochondria …

Oct 25, 2023 Mitochon was founded by Robert Alonso, MBA, and John Geisler, Ph.D., with the goal of creating disease­ modifying treatments for a variety of neurological …See details»

Mitochon Pharmaceuticals - Funding, Financials, Valuation

Mitochon Pharmaceuticals is funded by Ben Franklin Technology Partners of Southeastern Pennsylvania. Mitochon Pharmaceuticals has a post-money valuation in the range of …See details»

Mitochon Pharmaceuticals - PitchBook

Mitochon Pharmaceuticals Overview. Update this profile. Year Founded. 2014. Status. Private. Employees. 4. Latest Deal Type. Later Stage VC. (Cancelled) Investors. 5. …See details»

Mitochon Pharmaceuticals and University of Kentucky Awarded …

Sep 28, 2021 Mitochon was founded in 2015 with the mission to develop treatments for insidious diseases through the modulation of mitochondrial physiology, with applications …See details»

Mitochon Pharmaceuticals: Harnessing the Power of …

Mitochon is focused on developing MP-101 and MP-201, “disease-modifying” drugs that specifically target the mitochondria and attenuate neurodegeneration, with a focus on the diseases of Huntington’s & ALS …See details»

Pipeline » Mitochon Pharmaceuticals

European Medicines Agency (EMA) Greenlights Mitochon Pharmaceuticals to Initiate Phase I/IIa Biomarker Study in Neurodegenerative DiseasesSee details»

Mitochon Pharmaceuticals - Contacts, Employees, Board …

Mitochon Pharmaceuticals has 2 current employee profiles, including Founder & Chief Scientific Officer John G. Geisler.See details»

High absorption mitochondrial anti-aging system

Thanks to the high concentration of its active antioxidant ingredients, in synergy with its developed and patented P.AS.S technology, MITOCHON carries out a targeted action to …See details»

Mitochon Pharmaceuticals: Channeling the Ability of Mitochondria

Mitochon Pharmaceuticals: Channeling the Ability of Mitochondria to Create Resilient, Protective Cells in Neurodegeneration and Aging. Mitochon Pharmaceuticals was …See details»

MP 101 - Mitochon Pharmaceuticals - AdisInsight - Springer

Jan 13, 2024 Drug Profile. MP 101 - Mitochon Pharmaceuticals. Alternative Names: MP101 - Mitochon Pharmaceuticals. Latest Information Update: 13 Jan 2024. Price : …See details»

Who we are | Mitochon

Ettore Federici. and Silvia Buscaroli. United by love for science and a long human and professional partnership, Ettore Federici and Silvia Buscaroli are the soul of Mitochon, …See details»

News » Mitochon Pharmaceuticals

European Medicines Agency (EMA) Greenlights Mitochon Pharmaceuticals to Initiate Phase I/IIa Biomarker Study in Neurodegenerative Diseases. January 9, 2024.See details»

John G. Geisler - Founder & Chief Scientific Officer @ Mitochon ...

Overview. Number of Founded Organizations 1. CB Rank (Person) 698,848. Primary Job Title Founder & Chief Scientific Officer. Primary Organization. Mitochon …See details»

Mitochon Pharmaceuticals, Inc. Overview | SignalHire Company …

Overview. Mitochon Pharmaceuticals, Inc. is a private company that has been in the industry for 10 years. The company currently specializes in the Biotechnology, …See details»

WHO chief urges countries to finalise pandemic accord by deadline

1 day ago Drugmaker Amneal agrees to $270 million U.S. opioid settlement 8:00 AM PDT. Macro Matters Weaker US jobs data brings some relief to Fed. The head of the World …See details»

Mitochon Pharmaceuticals - Crunchbase

Organization. Mitochon Pharmaceuticals. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Similar Companies. Companies like …See details»

Mitochon Pharmaceuticals - Tech Stack, Apps, Patents

Jun 27, 2021 Overview. The intellectual property of Mitochon Pharmaceuticals includes 11 registered patents primarily in the ' Medical Or Veterinary Science; Hygiene ' category, …See details»